When there is no diagnostically significant rise in serum creatinine, neutrophil gelatinase-associated lipocalin can identify patients who probably have subclinical AKI and are at an elevated risk of adverse outcomes (60). The gene discussed is LCN2; the disease is acute kidney injury.